M Splanet Pharma ZAC DU Grand Launay Pharmaceutical Import Profile — France (DGFT 2022–2026)

Name: M Splanet Pharma ZAC DU Grand Launay Pharmaceutical Import Records from India — 3 Products, $322.9K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

M Splanet Pharma ZAC DU Grand Launay — Pharmaceutical Importer Profile (2026) | 3 Products, $322.9K Trade | TransData Nexus

M Splanet Pharma ZAC DU Grand Launay

Pharmaceutical Importer · France · Nutritional Supplements Focus · $322.9K Total Trade · DGFT Verified

M Splanet Pharma ZAC DU Grand Launay is a pharmaceutical importer based in France with a total trade value of $322.9K across 3 products in 2 therapeutic categories. Based on 16 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. M Splanet Pharma ZAC DU Grand Launay sources from 2 verified Indian suppliers, with Aurochem Pharmaceuticals India Private Limited accounting for 98.7% of imports.

M Splanet Pharma ZAC DU Grand Launay — Import Portfolio & Supplier Network

M Splanet Pharma ZAC DU Grand Launay import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to M Splanet Pharma ZAC DU Grand Launay?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Aurochem Pharmaceuticals India Private Limited	$916.0K	84	98.7%
Swiss Garnier Life Sciences	$11.8K	2	1.3%

M Splanet Pharma ZAC DU Grand Launay sources from 2 verified Indian suppliers across .

What Formulations Does M Splanet Pharma ZAC DU Grand Launay Import?

Formulation	Value	Ships
Pharmaceutical products-bonecare plus Each film coated tablet contains:glucosamine sulphate potassium chloride USP	$62.6K	2
Pharmaceutical products-oflozoleofloxacin & ornidazole tabletseach film coatedtablet contains:ofloxacin BP	$59.8K	2
Pharmaceutical products-feverlet forteaceclofenac paracetamol & chlorzoxazonetabletseach film coated tablet	$59.6K	4
Pharmaceutical products-welvit plusamino acids with vitamins & minerals capsules.Each capsule contains	$50.0K	1
Pharmaceutical products-defnil-pdiclofenac & paracetamol tabletseach uncoatedtablet contains : diclofenac sodium BP	$46.4K	3
Pharmaceutical products-aurother 80/480mgartemether & lumefantrine tabletseachuncoated tablet contains:artemether	$45.8K	2
Pharmaceutical products-oflozoleofloxacin & ornidazole tabletseach film coatedtablet contains :ofloxacin BP	$39.5K	1
Pharmaceutical products-claricin-500clarithromycin tablets USP 500mgeach filmcoated tablet contains	$38.9K	4
Pharmaceutical products-zolcer kit eachkit contains: 2 capsules/2 tablets eachofa omeprazole delayed	$31.5K	1
Pharmaceutical products-chondroflexglucososamine & chondroitin capsuleseach capsule contains :glucosamine sulfate	$29.6K	2
Pharmaceutical products-aurother 80/480mgartemether & lumefantrine tabletseachuncoated tablet contains :artemether	$26.6K	1
Pharmaceutical products-bonacef 400cefixime tablets uspeach film coated tabletcontains:cefixime USP as trihydrate eq.	$22.6K	1
Pharmaceutical products-aurother 80/480MG artemether & lumefantrine tabletseach uncoated tablet contains	$19.8K	1
Pharmaceutical products-aurother 80/480mgartemether & lumefantrine tablets Each uncoated tablet contains:artemether	$19.2K	1
Pharmaceutical products-chondroflexglucososamine & chondroitin capsules Each capsule contains:glucosamine sulfate	$18.6K	1

M Splanet Pharma ZAC DU Grand Launay imports 66 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Glucosamine	Nutritional Supplements	$140.3K	7	1.1%	17
2	Ornidazole	Advanced Antibiotics	$123.5K	5	0.7%	17
3	Chondroitin	Nutritional Supplements	$59.2K	4	1.2%	13

M Splanet Pharma ZAC DU Grand Launay imports 3 pharmaceutical products across 2 categories into France totaling $322.9K.

M Splanet Pharma ZAC DU Grand Launay — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

M Splanet Pharma ZAC DU Grand Launay is a French pharmaceutical importer and distributor headquartered at 4 Avenue Victor Grignard, 76120 Le Grand Quevilly, France. The company specializes in sourcing finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, primarily from India. These products are then distributed within the French market, serving various healthcare providers and institutions. The company's strategic location in Le Grand Quevilly positions it advantageously within France's pharmaceutical distribution network, facilitating efficient logistics and supply chain operations.

2Distribution Network

M Splanet Pharma ZAC DU Grand Launay operates a centralized distribution model from its facility in Le Grand Quevilly. This location serves as the primary hub for receiving imported pharmaceutical products and dispatching them to various destinations across France. While specific details about additional warehouse locations or logistics capabilities are not publicly disclosed, the company's import activities suggest a well-established network capable of meeting the demands of the French pharmaceutical market.

3Industry Role

In France's pharmaceutical supply chain, M Splanet Pharma ZAC DU Grand Launay functions as a pharmaceutical importer and distributor. By sourcing finished pharmaceutical formulations from international suppliers, particularly from India, the company plays a crucial role in ensuring the availability of a diverse range of medications within the French market. This position enables the company to meet the therapeutic needs of various healthcare providers and institutions across the country.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — M Splanet Pharma ZAC DU Grand Launay

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

M Splanet Pharma ZAC DU Grand Launay's sourcing strategy exhibits a high degree of concentration, with 98.7% of its imports originating from AUROCHEM PHARMACEUTICALS INDIA PRIVATE LIMITED. This single-source dependency indicates a strategic choice to maintain a streamlined supply chain, potentially benefiting from established relationships and favorable terms. However, such concentration also introduces risks related to supply chain disruptions, pricing fluctuations, and regulatory changes affecting the supplier. The company's limited engagement with other suppliers suggests a cautious approach to diversification, possibly due to considerations of quality control, cost efficiency, or contractual obligations.

2Supply Chain Resilience

The resilience of M Splanet Pharma ZAC DU Grand Launay's supply chain is closely tied to its reliance on AUROCHEM PHARMACEUTICALS INDIA PRIVATE LIMITED. The absence of backup suppliers and the limited diversity in imported formulations may pose challenges in the event of supply disruptions, such as production delays, shipping issues, or regulatory changes in India. Additionally, the company's focus on a narrow range of therapeutic categories—Nutritional Supplements and Advanced Antibiotics—limits its ability to adapt to shifts in market demand or therapeutic trends. To enhance supply chain resilience, the company might consider diversifying its supplier base and expanding its product portfolio to mitigate potential risks.

Importing Pharmaceuticals into France — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for France

1Regulatory Authority & Framework

In France, the primary regulatory authority overseeing pharmaceutical imports is the Agence nationale de sécurité du médicament et des produits de santé (ANSM). ANSM is responsible for ensuring the safety, efficacy, and quality of medicinal products available in the French market. Key legislation governing pharmaceutical imports includes the Public Health Code (Code de la santé publique), which outlines the requirements for marketing authorization, importation, and distribution of medicinal products. For Indian generics to be marketed in France, they must obtain a marketing authorization from ANSM, demonstrating compliance with French and European Union standards.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in France stipulate that all imported medicines must have a valid marketing authorization issued by ANSM. Additionally, the manufacturing facilities of foreign suppliers must adhere to Good Manufacturing Practice (GMP) standards recognized by the European Union, WHO, or PIC/S. Indian exporters seeking to supply M Splanet Pharma ZAC DU Grand Launay must ensure that their manufacturing processes comply with these GMP standards and that their products are authorized for sale in France. Obtaining wholesale distribution authorization is also necessary for entities involved in the distribution of medicinal products within France.

M Splanet Pharma ZAC DU Grand Launay — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

M Splanet Pharma ZAC DU Grand Launay's focus on Nutritional Supplements and Advanced Antibiotics aligns with current healthcare trends emphasizing preventive care and the treatment of infectious diseases. The demand for these products in France is driven by an aging population, increased health awareness, and the prevalence of chronic conditions. By importing these specific therapeutic categories, the company aims to meet the evolving needs of the French healthcare system and capitalize on market opportunities.

2Sourcing Profile

The company's sourcing strategy centers on generic drugs, particularly in the categories of Nutritional Supplements and Advanced Antibiotics. This focus allows M Splanet Pharma ZAC DU Grand Launay to offer cost-effective alternatives to branded medications, catering to a price-sensitive segment of the market. India's established reputation for producing high-quality generics makes it a strategic partner for sourcing these products. The company's procurement approach emphasizes quality assurance, regulatory compliance, and supply chain efficiency.

3Market Positioning

Seller's Guide — How to Become a Supplier to M Splanet Pharma ZAC DU Grand Launay

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with M Splanet Pharma ZAC DU Grand Launay, particularly if they can offer products that complement the company's existing portfolio in Nutritional Supplements and Advanced Antibiotics. Identifying gaps in the current sourcing strategy, such as unmet therapeutic needs or emerging market trends, could provide avenues for collaboration. However, potential suppliers must navigate the regulatory requirements and quality standards set by French authorities to establish a successful partnership.

2Requirements & Qualifications

Indian exporters aiming to supply M Splanet Pharma ZAC DU Grand Launay and the French market must ensure that their manufacturing facilities comply with GMP standards recognized by the European Union, WHO, or PIC/S. Products must have valid marketing authorizations from ANSM and meet French labeling and packaging requirements. Additionally, exporters should be prepared to provide documentation related to product quality, safety, and efficacy to facilitate the importation process.

3How to Approach

Frequently Asked Questions — M Splanet Pharma ZAC DU Grand Launay

What products does M Splanet Pharma ZAC DU Grand Launay import from India?

M Splanet Pharma ZAC DU Grand Launay imports 3 pharmaceutical products across 2 categories. Top imports: Glucosamine ($140.3K), Ornidazole ($123.5K), Chondroitin ($59.2K).

Who supplies pharmaceuticals to M Splanet Pharma ZAC DU Grand Launay from India?

M Splanet Pharma ZAC DU Grand Launay sources from 2 verified Indian suppliers. The primary supplier is Aurochem Pharmaceuticals India Private Limited (98.7% of imports, $916.0K).

What is M Splanet Pharma ZAC DU Grand Launay's total pharmaceutical import value?

M Splanet Pharma ZAC DU Grand Launay's total pharmaceutical import value from India is $322.9K, based on 16 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does M Splanet Pharma ZAC DU Grand Launay focus on?

M Splanet Pharma ZAC DU Grand Launay imports across 2 categories. The largest: Nutritional Supplements (61.8%), Advanced Antibiotics (38.2%).

Get Full M Splanet Pharma ZAC DU Grand Launay Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.